Dakota15
Senior Member (Voting Rights)
The American Association of Immunologists: 'Long COVID: An Often Invisible Disability'
'Lisa McCorkell, co-founder of the Patient-Led Research Collaborative (PLRC), knows firsthand the debilitating effects of Long COVID.'
'On February 26, 2025, at AAI’s first ever congressional briefing, McCorkell shed light on the reality of Long COVID as an often invisible and episodic disability—one that disrupts millions of lives yet remains widely misunderstood and underrecognized'
'Despite these challenges, there is a clear path forward. McCorkell stressed the need for sustained federal funding for research, including efforts to identify biomarkers and develop targeted treatments. Expanding clinical trials is crucial, as is meaningful patient engagement in research and policy discussions. '
'But for the more than 20 million Americans suffering from this condition, progress is not optional. “We must ensure that we are not set back, but that we continue to move forward,” McCorkell concluded. “This is a crisis, and we need a robust response to match its scale.”
'Lisa McCorkell, co-founder of the Patient-Led Research Collaborative (PLRC), knows firsthand the debilitating effects of Long COVID.'
'On February 26, 2025, at AAI’s first ever congressional briefing, McCorkell shed light on the reality of Long COVID as an often invisible and episodic disability—one that disrupts millions of lives yet remains widely misunderstood and underrecognized'
'Despite these challenges, there is a clear path forward. McCorkell stressed the need for sustained federal funding for research, including efforts to identify biomarkers and develop targeted treatments. Expanding clinical trials is crucial, as is meaningful patient engagement in research and policy discussions. '
'But for the more than 20 million Americans suffering from this condition, progress is not optional. “We must ensure that we are not set back, but that we continue to move forward,” McCorkell concluded. “This is a crisis, and we need a robust response to match its scale.”